21st Jun 2010 12:17
Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement. DATANG INTERNATIONAL POWER GENERATION CO., LTD. (a sino-foreign joint stock limited company incorporated in the People's Republic of China) (Stock Code: 991) OVERSEAS REGULATORY ANNOUNCEMENT ANNOUNCEMENT ON COMPLETION OF A PLAN TO INCREASE SHAREHOLDINGS IN DATANG INTERNATIONAL POWER GENERATION CO., LTD BY China Datang CorporationSpecial Notice:
The board of directors (the "Board") and all directors (the "Directors") of the Company warrant that there are no false representations and misleading statements contained in, or material omissions from this announcement, and severally and jointly accept the responsibility for the truthfulness, accuracy and completeness of the content of this announcement.
This announcement is made pursuant to Rule 13.09(2) of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited.
Datang International Power Generation Co., Ltd. (the "Company") received a notice from China Datang Corporation ("CDC"), the controlling shareholder of the Company, stating that China Datang Overseas Investment Co., Ltd. ("Overseas Investment Co"), a wholly-owned subsidiary of CDC, confirmed the proceeding of a plan to increase its shareholding in the Company by an amount not exceeding 2% of the total share capital of the Company via off-market transactions in Hong Kong since 11 February 2010. As at 21 June 2010, the amount of aggregated increased shareholding of Overseas Investment Co in the Company accounted for 1.998% of the total share capital of the Company. CDC confirmed that such plan has been completed. The Company announces the details as follows:
I. Details of the increase in holding of shares
On 11 February 2010, CDC purchased a portion of H shares of the Company through
Overseas Investment Co, a wholly-owned subsidiary of CDC, via off-market transactions
in Hong Kong. CDC also intended to continue to purchase H shares of the Company
through Overseas Investment Co via on-market or off-market transactions within 12
months from 11 February 2010, with the proportion of aggregated purchase not exceeding
2% of the total issued share capital of the Company (including the portion already
purchased as at 11 February 2010), and CDC undertook that they would not reduce their
respective shareholdings in the Company during the course of the share purchase plan
and the statutory period.
On 21 June 2010, CDC confirmed the share purchase plan has been completed.
As at 21 June 2010, CDC purchased 246,000,000 shares of the Company in aggregate,
representing 1.998% of the current total share capital of the Company, which amounts
to 12,310,037,578 shares. Upon completion of the share purchase plan, CDC directly
held 3,959,241,160 A shares of the Company and indirectly held 480,680,000 H shares
of the Company through Overseas Investment Co, the sum of which representing
approximately 36.07% of the current total issued share capital of the Company.
CDC has adhered to its undertaking and did not reduce its holding of shares in the
Company during the course of the share purchase plan.
II. Others
CDC will apply to the China Securities Regulatory Commission for the exemption on the
obligation of making a general offer in accordance with the relevant regulations. By Order of the Board Zhou Gang Secretary to the Board
Beijing, the PRC, 21 June 2010
As at the date of this announcement, the Directors of the Company are:
Zhai Ruoyu, Hu Shengmu, Cao Jingshan, Fang Qinghai, Zhou Gang, Liu Haixia, Guan Tiangang, Su Tiegang, Ye Yonghui, Li Gengsheng, Xie Songlin*, Liu Chaoan*, Yu Changchun*, Xia Qing* and Li Hengyuan*.
* Independent non-executive Directors
vendorRelated Shares:
Datang Intl H